Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS

April 14, 2020 updated by: University Hospital, Angers

Evaluation of Respiratory Mechanics and Lung Recruitment in Patients With SARS-CoV-2 Associated Acute Respiratory Distress Syndrome

The aim of this observationnal study is to describe respiratory mechanics and lung recruitement in patients with SARS-CoV-2 Associated Acute Respiratory Distress Syndrome who underwent invasive ventilation on endotracheal tube, admitted to the medical ICU of Angers university hospital . Statics measurements of respiratory system compliance were performed at 2 differents levels of PEEP (15 cmH2O and 5 cmH2O). The recruited volume is computed as the difference between the volume expired from PEEP 15 to 5 cmH2O and the volume predicted by compliance at PEEP 5 cmH2O . The recruitment-to-Inflation (R/I) ratio (i.e. the ratio between the recruited lung compliance and CRS at PEEP 5 cmH2O) is used to assess lung recruitability. A R/I ratio value higher than or equal to 0.5 was used to define highly recruiter patients.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

The investigators perform an observational prospective study in patients admitted to medical ICU in Angers University hospital with a confirmed COVID 19 pneumonia and who require invasive ventilation on endotracheal tube. Participants receive initially deep sedation and neuromuscular blockers for 24 hours and are ventilated in volume-controlled mode with a tidal volume of 6 mL/kg of predicted body weight, a constant inspiratory flow of 60 L/minute and a respiratory rate adjusted to maintain pH above 7.35 when possible. A PEEP decremental trial from 15 to 5 cmH2O was performed (15 minutes by step).

Esophageal pressure monitoring and electrical impedance tomography (EIT) are collected if available. Arterial blood gases and respiratory mechanics are measured at the end of each step.

The recruitment-to-Inflation (R/I) ratio (i.e. the ratio between the recruited lung compliance and CRS at PEEP 5 cmH2O) is used to assess lung recruitability. A R/I ratio value higher than or equal to 0.5 is used to define highly recruiter patients.

By the end of the recording time, a low-flow (5 L/min) inflation from PEEP 5 cmH2O (tidal volume = 6ml/kg PBW) is then performed after a prolonged expiration to identify a potential airway closure and the corresponding airway opening pressure (AOP).

Investigators perform these measurements at day 1, day 5 and day 10 from ICU admission if participants still require controlled ventilation.

The investigators also collect clinical data about each participant (past medical history, ICU discharge, hospital discharge, date of death, ventilator acquired pneumonia, thromboembolic event, use of NO, use of ECMO or renal replacement therapy).

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Mechanically Ventilated adult patients with COVID-19 Associated ARDS

Description

Inclusion Criteria:

  • ARDS criteria according to Berlin classification criteria
  • Invasive mechanical ventilation on endotracheal tube
  • SARS Cov-2 infection

Exclusion Criteria:

  • pneumothorax

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment-to Inflation ratio (R/I ratio)
Time Frame: Day 1
no unit
Day 1
Recruitment-to Inflation ratio (R/I ratio)
Time Frame: Day 5
no unit
Day 5
Recruitment-to Inflation ratio (R/I ratio)
Time Frame: Day 10
no unit
Day 10

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PaO2/FiO2 (mmHg)
Time Frame: Day 1
Arterial blood gases
Day 1
PaO2/FiO2 (mmHg)
Time Frame: Day 5
Arterial blood gases
Day 5
PaO2/FiO2 (mmHg)
Time Frame: Day 10
Arterial blood gases
Day 10
Lung volume recruited (VRec)
Time Frame: Day 1
mL
Day 1
Lung volume recruited (VRec)
Time Frame: Day 5
mL
Day 5
Lung volume recruited (VRec)
Time Frame: Day 10
mL
Day 10
Plateau pressure (cm H2O)
Time Frame: Day 1
Obtained by inspiratory pause of 5 seconds
Day 1
Plateau pressure (cm H2O)
Time Frame: Day 5
Obtained by inspiratory pause of 5 seconds
Day 5
Plateau pressure (cm H2O)
Time Frame: Day 10
Obtained by inspiratory pause of 5 seconds
Day 10
Oesophagal pressure (cm H2O)
Time Frame: Day 1
Day 1
Oesophagal pressure (cm H2O)
Time Frame: Day 5
Day 5
Oesophagal pressure (cm H2O)
Time Frame: Day 10
Day 10
weight (Kg)
Time Frame: Day 1
Day 1
weight (Kg)
Time Frame: Day 5
Day 5
weight (Kg)
Time Frame: Day 10
Day 10
urine output (mL)
Time Frame: day 1
day 1
urine output (mL)
Time Frame: day 5
day 5
urine output (mL)
Time Frame: day 10
day 10
serum creatinine (Umo/L)
Time Frame: day 1
day 1
serum creatinine (Umo/L)
Time Frame: day 5
day 5
serum creatinine (Umo/L)
Time Frame: day 10
day 10
Mean arterial pressure (mmHg)
Time Frame: day 1
day 1
Mean arterial pressure (mmHg)
Time Frame: day 5
day 5
Mean arterial pressure (mmHg)
Time Frame: day 10
day 10
Peak Pressure (cm H2O)
Time Frame: Day 1
Day 1
Peak Pressure (cm H2O)
Time Frame: Day 5
Day 5
Peak Pressure (cm H2O)
Time Frame: Day 10
Day 10
PEEP total (cm H2O)
Time Frame: Day 1
Obtained by expiratory pause of 5 seconds
Day 1
PEEP total (cm H2O)
Time Frame: Day 5
Obtained by expiratory pause of 5 seconds
Day 5
PEEP total (cm H2O)
Time Frame: Day 10
Obtained by expiratory pause of 5 seconds
Day 10
PEP Set (cm H2O)
Time Frame: Day 1
Day 1
PEP Set (cm H2O)
Time Frame: Day 5
Day 5
PEP Set (cm H2O)
Time Frame: Day 10
Day 10
Height (cm)
Time Frame: Day 1
Day 1
Airway pening pressure (cm H2O)
Time Frame: day 1
day 1
Airway pening pressure (cm H2O)
Time Frame: day 5
day 5
Airway pening pressure (cm H2O)
Time Frame: day 10
day 10
Expired volume in PEEP setted at 15 cmH2O (mL)
Time Frame: Day 1
respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted
Day 1
Expired volume in PEEP setted at 15 cmH2O (mL)
Time Frame: Day 5
respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted
Day 5
Expired volume in PEEP setted at 15 cmH2O (mL)
Time Frame: Day 10
respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted
Day 10
Expired volume in PEEP setted at 5 cmH2O (mL)
Time Frame: Day 1
respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted
Day 1
Expired volume in PEEP setted at 5 cmH2O (mL)
Time Frame: Day 5
respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted
Day 5
Expired volume in PEEP setted at 5 cmH2O (mL)
Time Frame: Day 10
respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted
Day 10

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: François BELONCLE, MCU PH, CHU Angers, Médecine intensive réanimation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 18, 2020

Primary Completion (Anticipated)

April 20, 2020

Study Completion (Anticipated)

December 31, 2020

Study Registration Dates

First Submitted

April 9, 2020

First Submitted That Met QC Criteria

April 14, 2020

First Posted (Actual)

April 17, 2020

Study Record Updates

Last Update Posted (Actual)

April 17, 2020

Last Update Submitted That Met QC Criteria

April 14, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID

Clinical Trials on PEEP trial

Subscribe